Recursion Class News Today : Breaking News, Live Updates & Top Stories | Vimarsana

StockWatch: After $50M from Nvidia, Investors Bullish on Recursion

StockWatch: After $50M from Nvidia, Investors Bullish on Recursion
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Nvidia bionemoNvidia gpusGil blumMani forooharScott schoenhausCatherined cathie woodEquity research analystRecursion pharmaceuticalsNeedham coSilicon valley basedManaging directorKeybanc capital marketsLeerink partnersRecursion classChief investment officerPortfolio manager catherine

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

Entered into agreements to acquire Cyclica and Valence to bolster digital chemistry and generative AI capabilities in order to further create new chemical composition of matter for novel biological. | May 8, 2023

United statesSalt lake cityChris gibsonRecursion pharmaceuticals incDevelopment expensesProgram generationCerebral cavernous malformationTarget gammaRecursion classCavernous malformationAdenomatous polyposisProficient ovarian cancerIndustrialized program generationShareholder meetingRecursion annual shareholder meetingProxy statement

American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence

An American biotech company is acquiring two Canadian startups in the artificial intelligence (AI) drug discovery space: Cyclica and Valence.

United statesSalt lake cityBenjamin bergenChris gibsonDaniel cohenYoshua bengioMelinda gates foundationInnovation economy councilUniversity of torontoCouncil of canadian innovatorsValence discoveryPerturba therapeuticsInnovation economyCanadian innovatorsRecursion class